GENE ONLINE|News &
Opinion
Blog

2025-11-07|

Capsella Bursa-Pastoris Extract Studied for Mitigating Oxidative Stress Induced by Triflumuron

by GOAI
Share To

A recent study has examined the potential of Capsella bursa-pastoris extract in mitigating stress caused by Triflumuron, a widely used insecticide. Researchers investigated the eco-friendly remediation capabilities of this plant extract, focusing on its ability to alleviate the harmful effects induced by exposure to Triflumuron. The findings highlight the possible role of natural compounds in addressing environmental and biological stress associated with chemical pesticides.

The study explored how Capsella bursa-pastoris extract interacts with Triflumuron-induced stress at a biochemical level. Researchers analyzed various parameters, including oxidative stress markers and cellular responses, to determine the effectiveness of the plant extract in reducing toxicity. The results showed measurable improvements in stress-related indicators when treated with the extract, suggesting its potential as an environmentally sustainable solution for pesticide remediation. Further research is needed to fully understand its mechanisms and practical applications in agricultural or ecological settings.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 7, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top